Ansolysen in the treatment of arterial hypertension.
作者信息
DAVIGNON A, LEMIEUX G, GENEST J
出版信息
Can Med Assoc J. 1956 May 15;74(10):802-7.
Abstract
摘要
相似文献
1
Ansolysen in the treatment of arterial hypertension.
Can Med Assoc J. 1956 May 15;74(10):802-7.
2
[Ansolysen in the treatment of hypertension].
Union Med Can. 1956 May;85(5):499-505.
3
[Pentapyrrolidinium (ansolysen) therapy of malignant hypertension].
Belg Tijdschr Geneesk. 1955 Aug 1;11(15):759-67.
4
[Pentapyrrolidinium (ansolysen) therapy of hypertension].
Ugeskr Laeger. 1954 Nov 11;116(45):1601-3.
5
Long-term management of hypertension with pentolinium tartrate (ansolysen).
J Am Med Assoc. 1955 Mar 19;157(12):999-1003. doi: 10.1001/jama.1955.02950290019006.
6
The treatment of severe arterial hypertension with pentolinium.
J Chronic Dis. 1956 Jun;3(6):597-609. doi: 10.1016/0021-9681(56)90156-4.
7
Initial control of hypertension with pentolinium tartrate.
Lancet. 1955 Jan 29;268(6857):224-8. doi: 10.1016/s0140-6736(55)90158-6.
8
[Treatment of hypertension with Pentolinium].
J Med (Oporto). 1956 Sep 22;31(713):129.
9
Serum cholesterol in pentolinium-treated arterial hypertension.
Circulation. 1958 Feb;17(2):176-9. doi: 10.1161/01.cir.17.2.176.
10
Treatment of the ambulatory hypertensive patient with pentolinium tartrate; a method for regulating dosage.
Am J Med Sci. 1956 Feb;231(2):140-50.
引用本文的文献
1
Management and concept of human arterial hypertension.
Can Med Assoc J. 1956 Oct 15;75(8):625-31.
本文引用的文献
1
Long-term management of hypertension with pentolinium tartrate (ansolysen).
J Am Med Assoc. 1955 Mar 19;157(12):999-1003. doi: 10.1001/jama.1955.02950290019006.
2
The treatment of essential hypertension with pentolinium tartrate combined with Rauwolfia alkaloids.
Br Med J. 1955 Apr 2;1(4917):817-8. doi: 10.1136/bmj.1.4917.817.
3
[Administration of hexamethonium to patients with severe hypertension].
Union Med Can. 1954 Nov;83(11):1210-7.
4
Methonium compounds in the angina of hypertension.
Lancet. 1954 May 1;266(6818):905-8. doi: 10.1016/s0140-6736(54)91525-1.
5
A clinical appraisal of pentapyrrolidinium (M&B 2050) in hypertensive patients.
Circulation. 1954 Apr;9(4):540-6. doi: 10.1161/01.cir.9.4.540.
6
7
New sympathicolytic agents.
Lancet. 1953 Mar 7;1(6758):455-7. doi: 10.1016/s0140-6736(53)91639-0.
8
Pharmacology of M. & B. 2050.
Lancet. 1953 Mar 7;1(6758):454-5. doi: 10.1016/s0140-6736(53)91638-9.
9
The methonium.
Pharmacol Rev. 1952 Sep;4(3):219-53.
Zotero 插件